Diagnostic accuracy of magnifying chromoendoscopy with detection of intestinal metaplasia and dysplasia using acetic acid in Barrett's esophagus

Gastroenterologie Clinique et Biologique

Volumn 30, Issue 2, 2006, Pages 217-223

  Réaud, Stéphane ^a   Croue, Anne ^a   Boyer, Jean ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CHROMOENDOSCOPY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DYSPLASIA; ESOPHAGUS BIOPSY; FEMALE; HISTOLOGY; HUMAN; INTESTINE BIOPSY; INTESTINE DYSPLASIA; INTESTINE METAPLASIA; MALE; SENSITIVITY AND SPECIFICITY;

EID: 33645537419     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(06)73156-6     Document Type: Article

References (61)

1. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295:476-80.
2. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996;110:614-21.
3. Chalasani N, Wo JM, Hunter JG, Waring JP. Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. Dig Dis Sci 1997;42:603-7.
4. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992;37:137-43.
5. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:212-5.
6. Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalosvki M. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol 1997;92:407-13.
7. Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol 1997;92:2012-6.
8. Sharma P. Recent advances in Barrett's esophagus: short-segment Barrett's esophagus and cardia intestinal metaplasia. Semin Gastrointest Dis 1999;10:93-102.
9. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992;102:1212-9.
10. Dent J, Bremner CG, Collen MJ, Haggitt RC, Spechler SJ. Barrett's oesophagus. J Gastroenterol Hepatol 1991;6:1-22.
11. The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc 1998;48:663-8.
12. Atkinson M. Barrett's oesophagus-to screen or not to screen? Gut 1989;30:2-5.
13. Trudgill NJ, Suvarna SK, Kapur KC, Riley SA. intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut 1997;41:585-9.
14. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998;93:1028-32.
15. Falk GW, Ours TM, Richter JE. Practice patterns for surveillance of Barrett's esophagus in the united states. Gastrointest Endosc 2000;52:197-203.
16. Wright TA, Gray MR, Morris AI, Gilmore IT, Ellis A, Smart HL, et al. Cost effectiveness of detecting Barrett's cancer. Gut 1996;39:574-9.
17. van der Burgh A, Dees J, Hop WC, van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996;39:5-8.
18. Clark GW, Ireland AP, DeMeester TR. Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment. Dig Dis 1996;14:213-27.
19. Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994;108:813-21.
20. van Sandick JW, van Lanschot JJ, Kuiken BW, Tytgat GN, Offerhaus GJ, Obertop H. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998;43:216-22.
21. Cooper GS, Yuan Z, Chak A, Rimm AA. Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia. Cancer 2002;95:32-8.
22. Guelrud M, Herrera I, Essenfeld H, Castro J. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 2001;53:559-65.
23. Cartier R. Practical colposcopy. Basel, Switzerland :Karger; 1978.
24. Lambert R, Rey JF, Sankaranarayanan R. Magnification and chromoscopy with the acetic acid test. Endoscopy 2003;35:437-45.
25. Woolf GM, Riddell RH, Irvine EJ, Hunt RH. A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett's) esophagus. Gastrointest Endosc 1989;35:541-4.
26. Stevens PD, Lightdale CJ, Green PH, Siegel LM, Garcia-Carrasquillo RJ, Rotterdam H. Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus. Gastrointest Endosc 1994;40:747-9.
27. Overholt BF, Panjehpour M. Photodynamic therapy for Barrett's esophagus. Gastrointest Endosc Clin N Am 1997;7:207-20.
28. Nothmann BJ, Wright JR, Schuster MM. In vivo vital staining as an aid to identification of esophagogastric mucosal junction in man. Am J Dig Dis 1972;17:919-24.
29. Burbige EJ, Radigan JJ. Characteristics of the columnar-cell lined (Barrett's) esophagus. Gastrointest Endosc 1979;25:133-6.
30. Stevens PD, Lightdale CJ, Green PH, Siegel LM, Garcia-Carrasquillo RJ, Rotterdam H. Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus. Gastrointest Endosc 1994;40:747-9.
31. Sharma P, Weston AP, Topalovski M, Cherian R, Bhattacharyya A, Sampliner RE. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut 2003;52:24-7.
32. Chobanian SJ, Cattau EL, Jr., Winters C, Jr., Johnson DA, Van Ness MM, Miremadi A, et al. In vivo staining with toluidine blue as an adjunct to the endoscopic detection of Barrett's esophagus. Gastrointest Endosc 1987;33:99-101.
33. Katzka D, Plotkin A, Saul S, Cohen S, Strom BL, Ouyang A, Reynolds JC. A controlled study of toluidine blue staining in patients with metaplasia of the esophagus. (Abstract) Gastroenterology 1986;90: 1485
34. Eisen GM, Montgomery EA, Azumi N, Hartmann DP, Bhargava P, Lippman M, et al. Qualitative mapping of Barrett's metaplasia: a prerequisite for intervention trials. Gastrointest Endosc 1999;50:814-8.
35. Tabuchi M, Sueoka N, Fujimori T. Videoendoscopy with vital double dye staining (crystal violet and methylene blue) for detection of a minute focus of early stage adenocarcinoma in Barrett's esophagus: a case report. Gastrointest Endosc 2001;54:385-8.
36. Sharma P, Topalovski M, Mayo MS, Weston AP. Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus. Gastrointest Endosc 2001;54:289-93.
37. Yagi K, Nakamura A, Sekine A. Accuracy of magnifying endoscopy with methylene blue in the diagnosis of specialized intestinal metaplasia and short-segment Barrett's esophagus in Japanese patients without Helicobacter pylori infection. Gastrointest Endosc 2003;58:189-95.
38. Canto MI, Setrakian S, Petras RE, Blades E, Chak A, Sivak MV, Jr. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 1996;44:1-7.
39. Canto MI, Setrakian S, Willis J, Chak A, Petras R, Powe NR, et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 2000;51:560-8.
40. Gangarosa LM, Halter S, Mertz H. Methylene blue staining and endoscopic ultrasound evaluation of Barrett's esophagus with low-grade dysplasia. Dig Dis Sci 2000;45:225-9.
41. Canto MI, Setrakian S, Willis JE, Chak A, Petras RE, Sivak MV. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study. Endoscopy 2001;33:391-400.
42. Kiesslich R, Hahn M, Herrmann G, Jung M. Screening for specialized columnar epithelium with methylene blue: chromoendoscopy in patients with Barrett' s esophagus and a normal control group. Gastrointest Endosc 2001;53:47-52.
43. Kiesslich R. Methylene blue facilitates diagnosis of specialized epithelium. Acta Endoscopica 2001, 31, 141-46.
44. Breyer HP, Silva De Barros SG, Maguilnik I, Edelweiss MI. Does methylene blue detect intestinal metaplasia in Barrett's esophagus? Gastrointest Endosc 2003;57:505-9.
45. Kouklakis GS, Kountouras J, Dokas SM, Molyvas EJ, Vourvoulakis GP, Minopoulos GI. Methylene blue chromoendoscopy for the detection of Barrett's esophagus in a Greek cohort. Endoscopy 2003;35:383-7.
46. Ragunath K, Krasner N, Raman VS, Haqqani MT, Cheung WY. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus. Endoscopy 2003;35:998-1003.
47. Wo JM, Ray MB, Mayfield-Stokes S, Al Sabbagh G, Gebrail F, Slone SP, et al. Comparison of methylene blue-directed biopsies and conventional biopsies in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a preliminary study. Gastrointest Endosc 2001;54:294-301.
48. Dave U, Shousha S, Westaby D. Methylene blue staining: is it really useful in Barrett's esophagus? Gastrointest Endosc 2001;53:333-5.
49. Egger K, Werner M, Meining A, Ott R, Allescher HD, Hofler H, et al. Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut 2003;52:18-23.
50. Peitz U, Vieth M, Kahl S, Roessner A, Malfertheiner P. The magnified endoscopic view of cardia-type mucosa. Z Gastroenterol 2004;42:371-7.
51. Endo T, Awakawa T, Takahashi H, Arimura Y, Itoh F, Yamashita K, et al. Classification of Barrett's epithelium by magnifying endoscopy. Gastrointest Endosc 2002;55:641-7.
52. Guelrud M, Herrera I. Acetic acid improves identification of remnant islands of Barrett's epithelium after endoscopic therapy. Gastrointest Endosc 1998;47:512-5.
53. Guelrud M, Herrera I, Essenfeld H, Castro J, Antonioli DA. intestinal metaplasia of the gastric cardia: A prospective study with enhanced magnification endoscopy. Am J Gastroenterol 2002;97:584-9.
54. Shrestha S, Xiao SY, Reeves AL, Waxman I. Can high resolution and high-magnification endoscopy accurately predict the presence of specialized intestinal metaplasia in patients with Barrett's esophagus and serve as a surrogate optical biopsy ? (abstract). Gastrointest Endosc 2001;53:AB121.
55. Meining A, Heldwein W. Magnification endoscopy for detection of specialized intestinal metaplasia at esophagogastric junction. Gastrointest Endosc 2003; 57:AB577.
56. Toyoda H, Rubio C, Befrits R, Hamamoto N, Adachi Y, Jaramillo E. Detection of intestinal metaplasia in distal esophagus and esophagogastric junction by enhanced-magnification endoscopy. Gastrointest Endosc 2004;59:15-21.
57. Olliver JR, Wild CP, Sahay P, Dexter S, Hardie LJ. Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus. Lancet 2003;362:373-4.
58. Rey JF, Kuznetsov K. Usefulness of chromoscopy with acetic acid and magnification for Barrett's esophagus (abstract). Gastrointest Endosc 2003;5:AB91.
59. De Weerth A, Brand B, Fritscher-Ravens A, Thonke F, Ameis D, Maydeo A, et al. High resolution zoom endoscopy combined with vital staining for improved acurate detection of dysplasia in Barrett's mucosa. Preliminary results from an ongoing study (abstract). Gastrointest Endosc 2001;53:AB160.
60. Guelrud M, Ehrlich EE. Endoscopic classification of Barrett's esophagus. Gastrointest Endosc 2004;59:58-65.
61. Meining A, Rosch T, Kiesslich R, Muders M, Sax F, Heldwein W. Inter- and intra-observer variability of magnification chromoendoscopy for detecting specialized intestinal metaplasia at the gastroesophageal junction. Endoscopy 2004;36:160-4.